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Gangliosides and neutral glycolipids of muscles from normal and dystrophic chickens were studied. Total 
glycolipid content of the degenerating muscles was higher than the normal muscles. In addition, the 
myopathic muscles contained a ganglioside which was absent in the unaffected muscles from normal and 
dystrophic chickens. Based on the thin-layer chromatographic mobility, treatment with neuraminidases 
from Vibrio cholerae and Arthrobacter ureafaciens, and reactivity of the asialo-derivative towards 
anti-ganglio-N-triaosylceramide antibody, the dystrophic-specific ganglioside was tentatively identified as 
GM~. Data obtained from young and old dystrophic chickens suggested a direct relationship of this 
ganglioside to muscular dystrophy. 
Ganglioside Neutral glycolipid Chicken muscular dystrophy GMZ Degenerating muscle 
Dystrophic-specific ganglioside 
1. INTRODUCTION 
Increasing evidence indicates that muscular 
dystrophy is a generalized membrane defect [l]. 
Glycolipids are vital membrane components and 
are involved in many biological functions [2-41. A 
number of studies concerning the identification of 
glycolipids in normal muscles have been reported 
[5-71. However, involvement of glycolipids in 
Abbreviations: CMH, galactosyl or glucosylceramide; 
CDH, lactosylceramide; CTH, globotriaosylceramide; 
LT, lactotriaosylceramide GlcNAc(fll-3)Gal(,61-4)- 
Glc-Cer; As GM& ganglio-N-triaosylceramide; PG, lac- 
toneotetraosylceramide Gal(Pl-4)GlcNAc(Pl-3)Gal- 
(fil-4)Glc-Cer; As GM~, ganglio-N-tetraosylceramide; 
Forss, Forssman glycolipid; SPG, sialosyllactoneotetra- 
osylceramide NeuAc(cu2-3)Gal(,61-4)GlcNAc(,&l-3)- 
Gal(bl-4)Glc-Cer; SNH, sialosyllacto-N-nor-hexaosyl- 
ceramide NeuAc(cu2-3)[Gal(~l-4)GlcNAc(~l-3)]~Gal- 
(fil -4)Glc-Cer 
The abbreviations for gangliosides of the ganglio series 
are as in [31]; for ganglioside structures see [32] 
myopathic conditions is not fully explored. 
Because of the histopathological similarities to 
human muscular dystrophy, chickens with in- 
herited muscular dystrophy serve as an excellent 
experimental model [8,9]. In [lo] a reduction in 
total neutral glycolipids was reported, especially 
Forssman glycolipid in pectoral and bicep muscles 
of newly-hatched dystrophic chicks compared to 
their normal counterparts. However, no data on 
the relationship between these changes to the 
severity and/or progression of muscular dystrophy 
was reported. Moreover, no information is 
available on the sialic acid containing glycolipids, 
gangliosides, which have been shown to influence 
myogenesis [ 111, formation of neuromuscular 
junctions [12] and nerve generation [13]. To 
understand the role of gangliosides in muscular 
dystrophy, we studied their distribution and con- 
tent in the affected and unaffected synergistic 
flight muscles of dystrophic chickens. We found 
that muscles undergoing degeneration contained a 
ganglioside which was absent in both normal and 
unaffected muscles. A tentative identification of 
this dystrophic ganglioside is discussed. 
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2. MATERIALS AND METHODS 2.3. Isolation and quantification of gangliosides 
2.1. Animals and neutral glycolipids 
New Hampshire chickens of genetic lines 412 
and 413 were obtained from the Department of 
Avian Sciences, University of California at Davis. 
These lines were developed from the Fz generation 
of a cross between the dystrophic line 304 and nor- 
mal New Hampshire chickens. Because of common 
origin, line 412 birds serve as genetically related 
normal controls to the homozygous dystrophic 
chickens of line 413. This genetic uniformity bet- 
ween the lines 412 and 413 is important in minimiz- 
ing the variation due to the background genes, 
which are known to modify the expression of the 
single dystrophic gene [ 141. 
The details of our procedure for isolation of 
glycolipids have been described in [20]. In brief, 
lipids were extracted with chloroform-methanol, 
1: 1 (v/v), and neutral and acidic lipids were 
separated on a column of DEAE-Sephadex A-25 
(Pharmacia Fine Chemicals, Piscataway NJ). The 
neutral glycolipids present in neutral lipid fraction 
were acetylated as in [21] and the ganglioside pre- 
sent in acidic lipid fraction was subjected to 
alkaline hydrolysis. Salts and other non-lipid con- 
taminants were removed by reversed-phase 
chromatography on a Cis Sep-Pak cartridge 
developed in [22]. 
Here, chickens at the early (5week-old) and the 
advanced (2.5year-old) stages of muscular 
dystrophy were used. Righting ability of all birds 
was evaluated by the exhaustion score method in 
[15]. In this method, the consecutive number of 
times a bird could rise from supine position in 
rapid succession during a single trial is counted. 
This method is very sensitive and highly reproduci- 
ble in evaluating the dystrophic condition [ 161. The 
anterior latissimus dorsi (ALD) and posterior 
latissimus dorsi (PLD) muscles were collected im- 
mediately after killing of animals. The PLD (fast 
muscle) is affected by muscular dystrophy. The 
ALD (slow muscle) is not affected by muscular 
dystrophy until 2 years of age [ 171. 
The yield of gangliosides in each preparation 
was determined by gas-liquid chromatographic 
(GLC) analysis of the lipid-bound sialic acid [23]. 
Thin-layer chromatography was performed on pre- 
coated silica gel 60 plates (E. Merck Labs., Darm- 
stadt). The thin-layer chromatography of 
gangliosides was performed with either 
chloroform-methanol-water, 55 : 45 : 10 (by vol.) 
containing 0.02% (w/v) of CaCl2.2 Hz0 or 
chloroform-methanol-2.5-N ammonia solution, 
60: 40 : 9 (by vol.). The thin-layer chromatography 
of neutral glycolipids was performed with 
chloroform-methanol-water mixtures (60: 35 : 4) 
or (60: 35 : 8) by vol. 
2.4. Enzymatic hydrolysis 
2.2. Enzymes and antibodies 
Neuraminidase of Vibrio cholerae was obtained 
from Behring Diagnostics (Sommerville NJ) and 
neuraminidase of Arthrobacter ureafaciens was 
from Boeringer Mannheim Biochemicals (In- 
dianapolis IN). ,&Galactosidase and P-N-acetyl- 
hexosaminidase from jack bean meal were kindly 
donated by Dr Y.-T. Li of Tulane University. 
Purified rabbit IgG antibody to lactotriaosyl- 
ceramide (LT), globotriaosylceramide (CTH), 
ganglio-N-triaosylceramide (As GMZ), globo- 
tetraosylceramide, ganglio-N-tetraosylceramide 
(As GM,), lactoneotetraosylceramide (PG) and 
Forssman glycolipid (Forss) have been prepared in 
this laboratory and well characterized [ 18,191. 
Mouse monoclonal anti-As GMZ was a gift from Dr 
S. Hakomori. Peroxidase-conjugated goat, anti- 
rabbit and anti-mouse Ig antibodies were obtained 
from Cappel Laboratories (Cochranville PA). 
In order to selectively cleave the terminal sialic 
acid, gangliosides (25-50 pg) were dissolved in 
200 ~1 50 mM acetate buffer (pH 5.0) containing 
2 mM CaCl2 and incubated with 10 units of I/. 
cholerae neuraminidase for 24 h at 37°C [24]. 
Neuraminidase from A. ureafaciens was used for 
the hydrolysis of all sialic acid residues [24,25]. 
Similar hydrolysis conditions were used except hat 
the acetate buffer contained 1 mg/ml sodium 
cholate and 100 mU enzyme. The hydrolysis of 
asialoglycolipids by &galactosidase (200 mU for 
25-50 pg glycolipid) and P-N-acetylhexosamini- 
dase (300 mU for 25 pg glycolipid) was carried out 
in 50 mM citrate buffer (pH 4.4) containing 
1 mg/ml sodium taurodeoxycholate for 24 h at 
37°C. After incubation with appropriate enzymes, 
1 ml chloroform-methanol 1: 1 was added and the 
reaction mixture was dried under nitrogen. The 
dried sample dissolved in 5 ml water and passed 
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through a Crs Sep-Pak cartridge. The glycolipid 
sample was eluted with chloroform-methanol 1: 2 
as in [22] and examined by thin-layer chromato- 
graphy. 
2.5. Irnmunoblot procedure for identification of 
glycolipids 
The procedure used was a modified technique of 
[26]. In our procedure, glycolipid samples 
(0.05-0.5 pg) were subjected to thin-layer 
chromatography on a high-performance 
aluminium backing plate (E. Merck) in a suitable 
solvent system as described above. After air dry- 
ing, the plate was immersed in hexane containing 
0.05% poly(isobutylmethylacrylate)-beads (Poly- 
sciences, Warrington PA) for 30 s. The plate was 
then sprayed with 0.02 M phosphate-buffered 
saline (PBS) (pH 7.3) and soaked in chilled PBS 
containing 1% bovine serum albumin (BSA) at 
4°C for 30 min. Excess buffer was removed from 
the plate. The purified antibody diluted with 
PBS-l% BSA (lo-50pg/ml IgG) was then 
overlayered on the plate and incubated overnight 
at 4°C. After washing the plate with PBS, the plate 
was overlayered as before with peroxidase- 
conjugated goat anti-rabbit Ig antibody (l/300 
dilution with PBS-l % BSA) and allowed to in- 
cubate for 4 h at 4°C. The plates were washed with 
PBS, and overlayered with freshly prepared 
substrate solution (3,3’-diaminobenzidine tetra- 
hydrochloride, 1 mg/ml, in water containing 
1 mg/ml imidazole to which 1 PI/ml hydrogen 
peroxide (30%) had been added) and allowed to 
react at room temperature. The positive bands ap- 
pear after 20 min of exposure to the substrate. 
3. RESULTS AND DISCUSSION 
Total ganglioside content of muscles from nor- 
mal and dystrophic chickens is summarized in 
table 1. An increase of -1.7-fold in the total 
ganglioside content was seen in PLD muscle of 
5-week-old dystrophic chicks as compared to PLD 
from age-matched normal chicks. In contrast to 
PLD muscle, unaffected ALD muscle in 
dystrophic chicks did not show a significant dif- 
ference in their ganglioside content. Total 
ganglioside content of PLD muscle of 2.5-year-old 
chickens was 2.2-times greater than that of normal 
chickens. The increase in ganglioside content of 
Table 1 
Concentration of gangliosides in normal and 
dystrophic chicken musclesa 
Age Type of 
musclesb 
Normal Dystrophic 
@g lipid-bound 
sialic acid/g wet muscle) 
5 weeks ALD 8.85 9.05 
PLD 5.4 9.2 
2.5 years ALD 9.55 11.32 
PLD 4.70 10.60 
“Determined by gas-liquid chromatography [23] 
bMuscles were pooled from 2-4 chickens in each group 
Fig. 1. Thin-layer chromatogram of 5-week-old 
chicken muscle gangliosides. The solvent was 
chloroform-methanol-water (60 : 40 : 9) containing 
0.02% CaClz .2 Hz0 (w/v) and gangliosides were 
detected with resorcinol reagent. Lanes ALD-nor 
contained gangliosides from 0.6 g, PLD-nor from 0.9 g, 
ALD-dys from 0.19 g and PLD-dys from 0.29 g wet 
muscles. Lane STD contained standard ganglioside 
mixture. The arrow in Lane PLD-dys indicates the 
dystrophic ganglioside; nor, normal; dys, dystrophic. 
The appearance of 2 bands for the dystrophic 
ganglioside is due to the heterogeneity in the ceramide 
moiety. Note that dystrophic ganglioside is absent in 
normal muscles in spite of a large amount of sample used 
for thin-layer chromatography separation. 
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dystrophic PLD muscles is greater in 2.5year-old 
chickens compared to young birds. This difference 
in muscle ganglioside content between young and 
old dystrophic birds is attributed to the severity of 
muscle degeneration, which correlated well with 
their righting ability. A slight increase in total 
ganglioside content of ALD muscles from 
2.5year-old birds was also observed (table 1). This 
increase coincides with the degenerative process 
which begins to affect the ALD muscles by 2 years 
of age [17]. Furthermore, ganglioside content of 
dystrophic PLD (fast) increased to a level of ALD 
(slow) muscles (table 1). Failure in the transition 
from slow to fast muscle types during embryonic 
development [27] may explain the similarities 
observed in ALD and PLD ganglioside content of 
dystrophic chickens. 
Thin-layer chromatography of gangliosides 
isolated from muscles of 5-week-old chicks and 
2.5year-old chickens are shown in fig. 1 and 
fig. 2, respectively. The major gangliosides iden- 
tified are &3, Go3, SPG and SNH. The identifica- 
tion of GMJ and Go3 was based on the thin-layer 
chromatography mobilities of the native 
gangliosides and their I/. cholerae neuraminidase 
hydrolysis product, lactosylceramide (CDH). SPG 
was identified by comparing its thin-layer 
chromatography mobility with that of a known 
standard [20]. The asialoglycolipid obtained from 
SPG after V. cholerae neuraminidase treatment 
Fig. 2. Thin-layer chromatogram of 2.5year-old chicken muscle gangliosides. The solvent was chloroform-methanol- 
water (60:40:9) containing 0.02% CaClz.2 Hz0 (w/v) and the gangliosides were detected with resorcinol reagent. 
Bands enclosed in square brackets were non-ganglioside impurities. Lanes ALD-nor, PLD-nor, ALD-dys and PLD-dys 
each contained gangliosides from 1 g of wet muscles; nor, normal; dys, dystrophic. STD lanes contained standard 
ganglioside mixtures. The arrows in lanes PLD-dys and ALD-dys indicate the new ganglioside which is absent in normal 
ALD and PLD muscles. 
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was identified as PC by the immunoblot procedure 
with purified antibody. The thin-layer 
chromatography mobilities of the two SNH bands 
obtained from muscles were identical to those of 
human erythrocytes SNH bands [29,30]. These two 
bands had the same carbohydrate chain but dif- 
fered from each other in their ceramide moiety. 
The principal fatty acid of the upper band was 
Cl6 :0, whereas the lower band contained a 
predominance of C22 :0, c24 : 0 and c24 : I. sue- 
cessive treatments of the muscle SNH bands with 
V. cholerae neuraminidase, 8-galactosidase and 
,B-N-acetylhexosaminidase gave 2 bands which 
were identified as lactoneotetraosylceramide by the 
immunoblot procedure. 
The most significant finding was the presence of 
a new ganglioside band (+, fig. 1) in dystrophic 
PLD muscles of 5-week-old chicks. This 
ganglioside had an apparent chromatographic 
mobility similar to GM~. The same ganglioside was 
also seen in PLD muscles from 2.5year-old 
chickens (fig. 2). However, this ganglioside was 
absent in PLD and ALD muscles of all normal 
chickens (fig. 1,2). In contrast to 5-week-old 
dystrophic chicks, ALD muscles of 2.5year-old 
dystrophic chickens contained this ganglioside. 
The presence of this ganglioside in ALD muscles of 
old dystrophic chickens is consistent with observa- 
tions that ALD muscles undergo degenerative 
changes at the late stage of disease progression 
[17]. Therefore we postulate a direct involvement 
of this ganglioside in the dystrophic process. 
The dystrophic-specific ganglioside was 
characterized by its susceptibility to neuraminidase 
treatment. V. cholerae neuraminidase failed to 
cleave sialic acid residue from this ganglioside. 
However, it was possible to cleave sialic acid by A. 
ureafaciens neuraminidase in the presence of bile 
salt. These data suggested that sialic acid was pre- 
sent on the internal sugar residue of the dystrophic- 
specific ganglioside molecule. Asialoglycolipid 
produced by A. ureafaciens neuraminidase 
hydrolysis was identified as As GMZ by im- 
munoblot procedure, using either mouse 
monoclonal or rabbit anti-As GMMZ antibodies. The 
thin-layer chromatography mobility, the suscep- 
tibility to neuraminidase treatment and the reac- 
tivity of asialo-derivative towards anti- 
As GMz-ceramide antibody suggest that the 
dystrophic-specific ganglioside has a carbohydrate 
structure similar to that of GMZ. 
The neutral glycolipid patterns of ALD and 
PLD muscles of 5-week- and 2.5year-old normal 
and dystrophic chickens are shown in fig. 3. An 
overall increase in neutral glycolipids was observed 
in dystrophic chickens of both age groups. The 
glycolipids tentatively identified on the basis of 
their reactivities towards specific antibodies by the 
immunoblot procedure are: LT, CTH, globo- 
tetraosylceramide, PG, As GM~ and Forss. The 
slow migrating bands seen below As GM~ were not 
identified (fig. 3). 
Preliminary results on glycolipid distribution in 
other affected muscles, namely pectoralis, showed 
a significant increase in both ganglioside and total 
neutral glycolipid content (not shown). Our results 
on neutral glycolipid content of pectoralis showed 
a trend opposite to that in [lo]. This difference 
could possibly be due to the fact that they used 
one-day-old white leghorn dystrophic chicks in- 
stead of 5-week-old and 2.5-year-old New Hamp- 
shire chickens used here. 
We have found that both neutral glycolipids and 
ganglioside contents are elevated in the affected 
muscles of dystrophic chickens. More significant- 
CMH- 
CDH- 
LT- 
CTH- 
Glob- 
PG 
Forss- 
As %I- 
STD ALD PLD ALD PLD STD 
Nor Nor Dys Dys 
Fig. 3. Thin-layer chromatogram of 2.5-year-old 
chicken muscle neutral glycolipids. The solvent was 
chloroform-methanol-water (60: 30: 5, by vol.) and 
glycolipids were detected with a-naphthol reagent, 
Bands enclosed in square brackets contain non- 
glycolipid impurities. Lanes ALD-nor, PLD-nor, ALD- 
dys and PLD-dys each contained glycolipids from 0.5 g 
wet muscles. STD lanes contained standard mixtures. 
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ly, we have demonstrated the presence of a 
dystrophic-specific ganglioside, tentatively iden- 
tified as GM2, in the affected muscles. These data 
suggest that this ganglioside may play a role in 
muscular dystrophy. Currently we are investigating 
the distribution, localization and metabolism of 
this ganglioside in various muscles of dystrophic 
chickens during embryonic development and post- 
natal growth. 
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